Kings Point Capital Management’s Zimmer Biomet ZBH Stock Holding History

Kings Point Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$13K	Sell	100 -3	-3%	-$362	﹤0.01%	551
2021 Q4	$13K	Hold	103	–	–	﹤0.01%	608
2021 Q3	$15K	Hold	103	–	–	﹤0.01%	525
2021 Q2	$16K	Hold	103	–	–	﹤0.01%	490
2021 Q1	$16K	Sell	103 -618	-86%	-$95.7K	﹤0.01%	481
2020 Q4	$108K	Hold	721	–	–	0.01%	236
2020 Q3	$95K	Buy	721 +618	+600%	+$80.7K	0.01%	239
2020 Q2	$12K	Hold	103	–	–	﹤0.01%	425
2020 Q1	$10K	Hold	103	–	–	﹤0.01%	450
2019 Q4	$15K	Hold	103	–	–	﹤0.01%	455
2019 Q3	$14K	Hold	103	–	–	﹤0.01%	446
2019 Q2	$12K	Hold	103	–	–	﹤0.01%	406
2019 Q1	$13K	Hold	103	–	–	﹤0.01%	342
2018 Q4	$10K	Hold	103	–	–	﹤0.01%	349
2018 Q3	$13K	Hold	103	–	–	﹤0.01%	345
2018 Q2	$11K	Hold	103	–	–	﹤0.01%	354
2018 Q1	$11K	Hold	103	–	–	﹤0.01%	363
2017 Q4	$12K	Hold	103	–	–	﹤0.01%	356
2017 Q3	$12K	Hold	103	–	–	﹤0.01%	349
2017 Q2	$13K	Hold	103	–	–	﹤0.01%	320
2017 Q1	$12K	Hold	103	–	–	﹤0.01%	337
2016 Q4	$10K	Hold	103	–	–	﹤0.01%	303
2016 Q3	$13K	Hold	103	–	–	﹤0.01%	289
2016 Q2	$12K	Hold	103	–	–	﹤0.01%	311
2016 Q1	$11K	Hold	103	–	–	﹤0.01%	315
2015 Q4	$10K	Buy	+103	New	+$10.1K	﹤0.01%	348

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kings Point Capital Management's ZBH Position: Q1 2022 in Review

Kings Point Capital Management reduced its Zimmer Biomet (ZBH) stake by 2.9% in Q1 2022, selling an estimated $362 and leaving 100 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

Kings Point Capital Management first reported a position in ZBH in Q4 2015 and has held it in 26 quarters since. The position peaked at $108K in Q4 2020. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Kings Point Capital Management held 100 shares of Zimmer Biomet worth $13K as of Q1 2022.
Kings Point Capital Management sold 3 Zimmer Biomet shares in Q1 2022, an estimated $362.
Zimmer Biomet made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #551 holding.
Kings Point Capital Management first reported a position in Zimmer Biomet in Q4 2015 and has held it in 26 quarters since.
Kings Point Capital Management's Zimmer Biomet position peaked at $108K in Q4 2020.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.